Cargando…
Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma
The US Food and Drug Administration recently announced the need to evaluate the association between PDE5is and melanoma. We performed a meta-analysis on the association between PDE5i and melanoma using random effects models and examined whether it met Hill's criteria for causality. A systematic...
Autores principales: | Loeb, Stacy, Ventimiglia, Eugenio, Salonia, Andrea, Folkvaljon, Yasin, Stattin, Pär |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5437700/ https://www.ncbi.nlm.nih.gov/pubmed/29117385 http://dx.doi.org/10.1093/jnci/djx086 |
Ejemplares similares
-
Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
por: Loeb, Stacy, et al.
Publicado: (2017) -
Phosphodiesterase (PDE)-4 Inhibitors and COPD Correlation with Cancer
por: Organtzis, John, et al.
Publicado: (2014) -
Nationwide, population‐based study of post radical prostatectomy urinary incontinence correction surgery
por: Ventimiglia, Eugenio, et al.
Publicado: (2017) -
Determination of Phosphodiesterase Type-5 Inhibitors (PDE-5) in Dietary Supplements
por: Gheorghiu, Oana Ramona Cătălina, et al.
Publicado: (2023) -
Multiple PDE5Is use as a marker of decreased overall men’s health: A real-life study
por: Oreggia, Davide, et al.
Publicado: (2018)